Next Article in Journal
Erratum: Managing Acute Promyelocytic Leukemia in Patients Belonging to the Jehovah’s Witness Congregation
Previous Article in Journal
Clinicopathological Study and Outcomes of Primary Extranodal Lymphoma
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Hematology Reports
Volume 11
Issue 4
10.4081/hr.2019.8281
hematolrep-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Splenomegaly Impacts Prognosis in Essential Thrombocythemia and Polycythemia Vera: A Single Center Study

by
Vincenzo Accurso
1,*,
Marco Santoro
2,
Simona Raso
2,
Angelo Davide Contrino
1,
Paolo Casimiro
1,
Florinda Di Piazza
2,
Alessandro Perez
2,
Antonio Russo
2 and
Sergio Siragusa
1
1
Hematology Division, University Hospital Policlinico “Paolo Giaccone”, Via del Vespro 129, 90127 Palermo, Italy
2
Department of Surgical, Oncological and StomatologicalDisciplines, University of Palermo, 90133 Palermo, Italy
*
Author to whom correspondence should be addressed.
Hematol. Rep. 2019, 11(4), 8281; https://doi.org/10.4081/hr.2019.8281
Submission received: 20 August 2019 / Revised: 20 October 2019 / Accepted: 18 November 2019 / Published: 4 December 2019

Abstract

Splenomegaly is one of the major clinical manifestations of primary myelofibrosis and is common also in other chronic Philadelphia-negative myeloproliferative neoplasms, causing symptoms and signs and affecting quality of life of patients diagnosed with these diseases. We aimed to study the impact that such alteration has on thrombotic risk and on the survival of patients with essential thrombocythemia and patients with Polycythemia Vera (PV). We studied the relationship between splenomegaly (and its grade), thrombosis and survival in 238 patients with et and 165 patients with PV followed at our center between January 1997 and May 2019.
Keywords: splenomegaly; polycythemia vera; essential thrombocythemia splenomegaly; polycythemia vera; essential thrombocythemia

Share and Cite

MDPI and ACS Style

Accurso, V.; Santoro, M.; Raso, S.; Contrino, A.D.; Casimiro, P.; Di Piazza, F.; Perez, A.; Russo, A.; Siragusa, S. Splenomegaly Impacts Prognosis in Essential Thrombocythemia and Polycythemia Vera: A Single Center Study. Hematol. Rep. 2019, 11, 8281. https://doi.org/10.4081/hr.2019.8281

AMA Style

Accurso V, Santoro M, Raso S, Contrino AD, Casimiro P, Di Piazza F, Perez A, Russo A, Siragusa S. Splenomegaly Impacts Prognosis in Essential Thrombocythemia and Polycythemia Vera: A Single Center Study. Hematology Reports. 2019; 11(4):8281. https://doi.org/10.4081/hr.2019.8281

Chicago/Turabian Style

Accurso, Vincenzo, Marco Santoro, Simona Raso, Angelo Davide Contrino, Paolo Casimiro, Florinda Di Piazza, Alessandro Perez, Antonio Russo, and Sergio Siragusa. 2019. "Splenomegaly Impacts Prognosis in Essential Thrombocythemia and Polycythemia Vera: A Single Center Study" Hematology Reports 11, no. 4: 8281. https://doi.org/10.4081/hr.2019.8281

Article Metrics

Back to TopTop